{"disease":{"id":"chimeric-antigen-receptor-t-cell-therapy","name":"chimeric antigen receptor t cell therapy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06890091","title":"Study of the Association Between Fatigue Experienced by Patients and the Specific Side Effects of CART Cells, During the First Month After Administration for Non-Hodgkin's Lymphoma","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT06041815","title":"Correlation Between Gut Microbiota and Clinical Response to CAR-T Treatment for Hematological Malignancies","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT05752877","title":"Safety and Efficacy of Targeted IL-13 Rα2 or B7-H3 UCAR-T for Advanced Glioma","phase":"NA","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Second Affiliated Hospital of Soochow University","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}